Here, we found that Gfi1b deletion increased OXPHOS and FAO in AML cells, which is interestingly consistent with the metabolic features of shorter survival AML patients, cytarabine-resistant AML cells, and LSCs. The gene discussed is GFI1B; the disease is acute myeloid leukemia.